Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Trends in death from multiple myeloma with concomitant diabetes mellitus in the USA

View Full Paper
Ask AI
Bookmark
Share

Authors

GGGunwant Guron

Discussion

Loading...

Member takes

Overview

Analysis of mortality trends among patients with diabetes mellitus and multiple myeloma indicates significant disparities by gender, race, and region.

Key Points

  • Mortality rates from multiple myeloma with diabetes mellitus increased across the US over 21 years, indicating a critical public health concern.
  • Age-adjusted mortality rates over the period showed significant differences by demographics, with rural areas facing higher risks.
  • Statistical analysis revealed marked regional and racial variances, with Non-Hispanic Whites experiencing lower mortality compared to other groups.
  • Enhanced diabetes management is essential to improve survival rates in multiple myeloma patients, emphasizing the interaction of both diseases.

Cite This Study

Gunwant Guron (2025) studied this question.

synapsesocial.com/papers/69362f7d4fa91c937236e4e8https://doi.org/10.1182/blood-2025-7528
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trends in mortality from multiple myeloma and diabetes mellitus in the United States: A retrospective analysis from 1999 to 20202025
  2. 2Trends in Acute Myeloid Leukemia mortality among patients with diabetes mellitus in the United States, 1999–2024: A CDC wonder database analysis2025
  3. 3Rising mortality trends in elderly multiple myeloma patients with hypertension: A CDC wonder database analysis (1999–2023)2025
  4. 4Racial, geographic, and gender disparities in ischemic heart disease mortality in patients with multiple myeloma: A nationwide analysis (1999–2023).2025
  5. 5Trends and disparities in mortality due to coexisting respiratory infections and multiple myeloma among middle-aged and older adults in the United States.2026